A Study to Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection
Clinical trial NCT05297565 · COMPLETED
Trial details
- NCT number
- NCT05297565
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-02
- Primary completion
- 2024-02-08
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.